2013-08-26 14:27:54 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Lombard Medical Technologies PLC (LMT) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Lombard Medical Technologies PLC (LMT). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Lombard Medical Technologies PLC investor.
Report Summary: Lombard Medical Technologies PLC is a below average quality company with a negative outlook. Lombard Medical Technologies PLC has medium business growth and is run by inefficient management. The trend in Lombard Medical Technologies PLC fair value exchange rate against its closest rated-competitor, Toumaz Ld, has been depreciating over the past 2 weeks. When compared to its closest competitor, Lombard Medical Technologies PLC shows similar undervaluation and is equally likely to outperform the market.
The report breaks down
the Total StockMark into its three components - business, management and price, performing an in-depth analysis of Lombard Medical Technologies PLC for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 20,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.